ViziLite TBlue, Oral Cancer sScreening Adjunct – Pack of 10

£137.50 excl. VAT+Carg.

ViziLite TBlue set includes 10x single-use handpieces, 10x single-use light guides, 10x 30ml oral cleanser, 1x TBlue singel-use marking system

Accessories/ refills – sold separately:
Optional angled retractor mirror for handpiece pack of 6
TBlue refill pack of 6
Vizi goggles, optional for clinician when room lights can not be dimmed (also bought as comfortable protective eyewear for patients in general surgery, especially useful over patient’s eye glasses)

Have a question about this product? Use the Enquiry Form (below) and we'll be happy to answer.

Product price
excl. VAT+Carg.
Additional options total:
excl. VAT+Carg.
Order total:
excl. VAT+Carg.
SKU: 88.650.199 Category:

Biopsy under clinical evaluation only, at a specialist referral clinic,  remains the mainstay of pre-cancer & oral cancer diagnosis. Adjuncts are used solely as an aid to enhance a clinical oral examination.

DenMat’s ViziLite® TBlue® is used to help oral healthcare professionals identify, evaluate, monitor and mark abnormal oral cell lesions suspicious for pathology including precancerous and cancerous cells that may be difficult to see during a regular visual clinical exam. ViziLite® TBlue® is a single use, easy-to-use, disposible System.

ViziLite TBlue Advantage:

  • Quick and easy-to use system that incorporates seamlessly into your standard visual examination – procedure only takes 2 minutes to complete

  • Small device size enables easier access to see and focus light inside the oral cavity

  • Disposable technology eliminates cross-contamination and improves infection control

  • Patented and clinically proven technology that has been helping healthcare professionals for more than a decade

  • Clinical studies has shown that the use of ViziLite TBlue after a conventional visual clinical examination resulted in:

    • NO FALSE NEGATIVE OUTCOMES, meaning in this clinical study ViziLite TBlue identified every lesion that had precancerous or cancerous cells

    • SIGNIFICANTLY REDUCED the number of false positive lesions identified during standard visual examinations – limiting the number of biopsies that may have normally been performed

Additional information

Manufacturer

Audience

,

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.